I'm Replacing My Acquired 2022 Stock Pick of the Year With Its Acquirer

Collegium Pharmaceutical should benefit greatly from its pending purchase of my stock pick for this year, BioDelivery Sciences International.

Crown Enters End Game in A$8.9 Billion Sale to Blackstone

Australia's largest casino operator moves into final talks with Blackstone, and the board encourages investors to approve deal.

What Recent Talk About Softbank and Alibaba Says About Both Firms

A chaotic news cycle has led to an equally wild swing in the share price of both names in the past week.

I Do Think Peloton Will Be Bought: Here's How I'm Playing It

PTON reported earnings Tuesday morning, and there's no way to sugarcoat the revised full year guidance.

Is Nike's Winning Streak About to End?

The athletic apparel maker's chart indicates its run could be over as it flashes bearish signals; meanwhile, it looks like Peloton may have put in a bottom.

Market Fun House, Bond Yields, Nord Stream 2, Raytheon, Steel, No Dice Nvidia

I had actually worried a bit that Arm was going to take Jensen Huang's eye off of the ball. That worry can now be put to bed.

Why Sony's Jump for Bungie Makes Videogame Sense

The PlayStation maker likely will introduce a subscription service later this year, hence the planned buyout of "Destiny" developer Bungie.

Charts: Kohl's Stock Gaps Higher as Activists Circle

Let's see what the charts can tell us.

Takeover Interest in Kohl's at a Fever Pitch: Here's My Plan

I always thought Kohl's was for sale, I just always thought it would be Amazon.

Activision Blizzard's Deal With Microsoft Perks Up a Portfolio of Losers

The video game maker is part of the 2022 Tax Loss Selling Recovery Portfolio and its pending acquisition has given the portfolio a lift.